Evidence-based value and access strategies

Case Study: Competitive Intelligence

Return to Clinical & Market Access Intelligence

A large pharma company engaged Compass to conduct a strategic assessment of the metabolic profiles of the company and its competitors

Client requested strategies to take advantage of opportunities and address potential gaps over the next 10 years in the metabolic space

Key Objective:
Characterize management of metabolic portfolios among ten key pharmaceutical companies with R&D programs in discovery and development of new agents and / or delivery systems to treat metabolic disorders


  • Primary research through telephone interview of US and EU KOLs (n=7), external commercial / R&D / BD executives (n=32) and client commercial / R&D executives for an assessment of the competitive situation, identification of attributes leading to long term success, and rating of portfolios
  • Primary research through an online survey of 14 business development external execs to prioritize attributes and rate companies


  • Ranking of metabolic companies and key strengths and weakness of client
  • Identification of competitors that will challenge client’s portfolio
Sample Deliverable
Top attributes selected by respondents were used to rank the metabolic companies